(Q34325583)

1 August 2017

A prospective evaluation of a breast cancer prognosis signature in the observational RASTER study (English)

1 reference

1 August 2017

1 reference

12

M J van de Vijver

1 reference

1 August 2017

11

E J T Rutgers

1 reference

1 August 2017

C A Drukker

1

1 reference

1 August 2017

J M Bueno-de-Mesquita

2

1 reference

1 August 2017

V P Retèl

3

1 reference

1 August 2017

W H van Harten

4

1 reference

1 August 2017

H van Tinteren

5

1 reference

1 August 2017

J Wesseling

6

1 reference

1 August 2017

R M H Roumen

7

1 reference

1 August 2017

M Knauer

8

1 reference

1 August 2017

L J van 't Veer

9

1 reference

1 August 2017

G S Sonke

10

1 reference

1 August 2017

S C Linn

13

1 reference

1 August 2017

language of work or name

English

0 references

publication date

4 March 2013

1 reference

1 August 2017

8

1 reference

International Journal of Cancer

inferred from page(s)

published in

1 reference

1 August 2017

133

1 reference

1 August 2017

4

1 reference

1 August 2017

929-936

1 reference

Comparisons between different polychemotherapy regimens for early breast cancer: meta-analyses of long-term outcome among 100,000 women in 123 randomised trials

1 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3734625

Impact of mammographic screening on the detection of good and poor prognosis breast cancers

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3734625

Quality of Life Differences between Younger and Older Breast Cancer Patients.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3734625

Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomised trials

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3734625

Can some patients avoid adjuvant chemotherapy for early-stage breast cancer?

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3734625

The 70-gene prognosis signature predicts early metastasis in breast cancer patients between 55 and 70 years of age.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3734625

Commercialized multigene predictors of clinical outcome for breast cancer.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3734625

Adjuvant chemotherapy in oestrogen-receptor-poor breast cancer: patient-level meta-analysis of randomised trials

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3734625

Use of 70-gene signature to predict prognosis of patients with node-negative breast cancer: a prospective community-based feasibility study (RASTER).

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3734625

Converting a breast cancer microarray signature into a high-throughput diagnostic test.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3734625

Gene signature evaluation as a prognostic tool: challenges in the design of the MINDACT trial

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3734625

Breast cancer: achievements in adjuvant systemic therapies in the pre-genomic era.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3734625

Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3734625

Population-based validation of the prognostic model ADJUVANT! for early breast cancer

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3734625

A gene-expression signature as a predictor of survival in breast cancer

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3734625

Computer program to assist in making decisions about adjuvant therapy for women with early breast cancer

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3734625

Cost-effectiveness of the 70-gene signature versus St. Gallen guidelines and Adjuvant Online for early breast cancer

6 July 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23371464

12 December 2020

inferred from PubMed ID database lookup

Validation of 70-gene prognosis signature in node-negative breast cancer

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23371464

12 December 2020

inferred from PubMed ID database lookup

Proposal for standardized definitions for efficacy end points in adjuvant breast cancer trials: the STEEP system

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23371464

12 December 2020

inferred from PubMed ID database lookup

Identifiers

DOI

10.1002/IJC.28082

1 reference

release_ocdaix5tlrd5nm5kguq5hob75y

1 August 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/ocdaix5tlrd5nm5kguq5hob75y

24 November 2022

mapped directly with Wikidata item

PMCID

3734625

1 reference

1 August 2017

1 reference